These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 20565364

  • 21. Posttransplant proteinuria is associated with higher risk of cardiovascular disease and graft failure in renal transplant patients.
    Ibis A, Akgül A, Ozdemir N, Colak T, Sezer S, Arat Z, Haberal M.
    Transplant Proc; 2009 Jun; 41(5):1604-8. PubMed ID: 19545689
    [Abstract] [Full Text] [Related]

  • 22. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM, Bakr MA, Metwally AH, Wahab AM.
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [Abstract] [Full Text] [Related]

  • 23. Impact of patterns of proteinuria on renal allograft function and survival: a prospective cohort study.
    Suhail SM, Kee TS, Woo KT, Tan HK, Yang WS, Chan CM, Foo MW, Li HH, Siddique MM, Wong KS.
    Clin Transplant; 2011 Mar; 25(3):E297-303. PubMed ID: 21362048
    [Abstract] [Full Text] [Related]

  • 24. Chronic allograft nephropathy and nephrotic range proteinuria.
    Ramanathan V, Suki WN, Rosen D, Truong LD.
    Clin Transplant; 2005 Jun; 19(3):413-7. PubMed ID: 15877807
    [Abstract] [Full Text] [Related]

  • 25. Detection of Hepatis C Virus-Related Immunologic Markers and Their Impact on Outcomes of Living-Donor Kidney Transplant Recipients.
    Denewar AA, Abbas MH, Sheashaa HA, Abdelaal I, El-Dahshan K, Matter YE, Refaie AF.
    Exp Clin Transplant; 2019 Feb; 17(1):79-83. PubMed ID: 29957163
    [Abstract] [Full Text] [Related]

  • 26. Renal transplantation offers a better survival in HCV-infected ESRD patients.
    Sezer S, Ozdemir FN, Akcay A, Arat Z, Boyacioglu S, Haberal M.
    Clin Transplant; 2004 Oct; 18(5):619-23. PubMed ID: 15344970
    [Abstract] [Full Text] [Related]

  • 27. Risk factors and outcomes of new-onset diabetes after transplant: single-centre experience.
    Al-Ghareeb SM, El-Agroudy AE, Al Arrayed SM, Al Arrayed A, Alhellow HA.
    Exp Clin Transplant; 2012 Oct; 10(5):458-65. PubMed ID: 22943190
    [Abstract] [Full Text] [Related]

  • 28. Clinical course of hepatitis C virus infection in renal transplant recipients.
    Savas N, Ocal S, Colak T, Karakayali H, Yilmaz U, Haberal M.
    Transplant Proc; 2007 May; 39(4):984-6. PubMed ID: 17524869
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Impact of hepatitis C virus on renal transplantation: association with poor survival.
    Pedroso S, Martins L, Fonseca I, Dias L, Henriques AC, Sarmento AM, Cabrita A.
    Transplant Proc; 2006 May; 38(6):1890-4. PubMed ID: 16908314
    [Abstract] [Full Text] [Related]

  • 33. [Correlation between the onset of early proteinuria and the outcome of renal transplantation. Experience of a single centre].
    Infante B, Stallone G, Schena A, Di Paolo S, Grandaliano G, Schena FP.
    G Ital Nefrol; 2002 May; 19(4):446-50. PubMed ID: 12369048
    [Abstract] [Full Text] [Related]

  • 34. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of growth in low-body-weight kidney transplant Egyptian children: 25-year experience.
    Mosaad AM, Hamdy AF, Hassan NM, Donia AF, Gheith O, Salem Mel-S, El-Shahawy el-ML, Bakr MA, Ghoneim MA.
    J Nephrol; 2012 Nov; 25(3):363-72. PubMed ID: 22081295
    [Abstract] [Full Text] [Related]

  • 36. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 37. Recurrent IgA nephropathy in renal transplant allografts.
    Wang AY, Lai FM, Yu AW, Lam PK, Chow KM, Choi PC, Lui SF, Li PK.
    Am J Kidney Dis; 2001 Sep 20; 38(3):588-96. PubMed ID: 11532693
    [Abstract] [Full Text] [Related]

  • 38. Late failure or human renal transplants. An analysis of transplant disease and graft failure among 125 recipients surviving for one to eight years.
    Petersen VP, Olsen TS, Kissmeyer-Nielsen F, Bohman SO, Hansen HE, Hansen ES, Skov PE, Solling K.
    Medicine (Baltimore); 1975 Jan 20; 54(1):45-71. PubMed ID: 235063
    [Abstract] [Full Text] [Related]

  • 39. Outcomes of renal transplantation after end-stage renal disease due to diabetic nephropathy: a single-center experience.
    Tokodai K, Amada N, Kikuchi H, Haga I, Takayama T, Nakamura A.
    Transplant Proc; 2012 Jan 20; 44(1):77-9. PubMed ID: 22310584
    [Abstract] [Full Text] [Related]

  • 40. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
    Kuo PC, Luikart H, Busse-Henry S, Hunt SA, Valantine HA, Stinson EB, Oyer PE, Scandling JD, Alfrey EJ, Dafoe DC.
    Clin Transplant; 1995 Apr 20; 9(2):92-7. PubMed ID: 7599409
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.